Table 2.

Number of hypersensitivity reactions to intravenous iron formulations according to the U.S. Food and Drug Administration Adverse Event Reporting System database that included all of the population aged over 6 years [10] and incidence rate of anaphylaxis according to insurance claims from Medicare, U.S., in older people [11].

	Hypersensitivity Reaction (n) [10]	Anaphylactic Reaction (n) [10]	Deaths (n) [10]	Adjusted Incidence Rate of Anaphylaxis in 10,000 First Administrations [11]
Iron dextrans	57	22	4	9.8
Iron sucrose	212	43	7	1.2
Ferumoxytol	196	67	23	4
Ferric carboxymaltose	401	51	1	0.8